title: [Control of blood sugar and beta blockers in the diabetic patient].
abstract: 30% of diabetics have arterial hypertension. 25% of patients with hypertension are diabetics. The rapid development of atherosclerosis is the main cause of morbidity and mortality among diabetics. Occasionally, prescription of a beta-blocking agent may seem rational in diabetics (hypertension, angina pectoris, etc.). But is such a medication acceptable considering the patient's fragile metabolic control? After a brief review of the pharmacology of the various beta-blocking agents, we discuss the choice of the best medication for the diabetic patient. Cardioselective beta-blockers seem to be best suited to diabetics. After insulin-induced hypoglycemia, rise in blood sugar level is less delayed and symptoms of hypoglycemia are less attenuated.
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy; D006801:Humans
chemical_list: D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose
vernacular_title: La régulation glycémique et le blocage bêta chez le patient diabétique.